-transparent.png){kind=logo}
Ceftriaxone (CTRX) was clinically evaluated and its pharmacokinetics studied in neonates. The results obtained are summarized below. 1. Blood levels of CTRX at 8 to 12 hours after intravenous injection with a single dose of 10 to 20 mg/kg ranged from 14.9 to 32.8 micrograms/ml, while T1/2 ranged from 8.2 to 24.8 hours. 2. Blood levels of CTRX at 11 hours after the completion of drip infusion which lasted one hour with a dose level 10 to 20 mg/kg, ranged from 10.6 to 25.0 micrograms/ml, while T1/2 was 5.4 to 22.8 hours. 3. Multiple intravenous administrations were given to premature infants, but blood levels did not show evidence of drug accumulation. 4. Urinary excretion in 6 hours after an intravenous injection or a drip infusion with 10 approximately 20 mg/kg of CTRX ranged from 13.8 to 58.5% of the dosage. 5. The subjects in this study were 9 neonates with suspected sepsis, pneumonia, Staphylococcus epidermidis or Staphylococcus aureus infections (sepsis, staphylococcal scalded skin syndrome, pneumonia), acute bronchitis or meconium aspiration syndrome. Efficacies CTRX were excellent or good in all these cases administered in a daily dose of 19.5 to 41.6 mg/kg for 4 to 11 days. 6. No general side effects or abnormalities were observed in blood count, or hepatic or renal function.
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
July 1975,
Pediatrics,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
April 1988,
American journal of veterinary research,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
February 1988,
The Japanese journal of antibiotics,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
April 1962,
Klinische Wochenschrift,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
November 1983,
Antimicrobial agents and chemotherapy,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
February 1969,
Archives of internal medicine,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
January 1984,
Arzneimittel-Forschung,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
April 2003,
Journal of chemotherapy (Florence, Italy),
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
August 1953,
The Journal of clinical endocrinology and metabolism,
S Nakazawa, and
H Satoh, and
A Narita, and
H Suzuki, and
S Nakazawa, and
K Matsumoto, and
Y Nakanishi, and
K Niino, and
H Chikaoka, and
M Kamigaki
March 1988,
The Japanese journal of antibiotics,
